Search Within

Role of Nanotechnology for Enzyme Replacement Therapy in Lysosomal Diseases. A Focus on Gaucher’s Disease

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 9
Page: 929-952
Authors: L. Martín-Banderas, M.A. Holgado, M. Durán-Lobato, J.J. Infante, J. Álvarez-Fuentes and M. Fernández-Arévalo

Mitochondrial Dysfunctions in Bipolar Disorder: Effect of the Disease and Pharmacotherapy

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 2
Page: 176-186
Authors: Tereza Cikankova, Ekaterina Sigitova, Martina Zverova, Zdenek Fisar, Jiri Raboch and Jana Hroudova

Combined Therapies for Lysosomal Storage Diseases

Journal: Current Molecular Medicine
Volume: 15,Issue: 8
Page: 746-771
Authors: M. Gabig-Cimińska, J. Jakóbkiewicz-Banecka, M. Malinowska, A. Kloska, E. Piotrowska, I. Chmielarz, M. Moskot, A. Węgrzyn and G. Węgrzyn

Current Drug Managements of Wilson’s Disease: From West to East

Journal: Current Neuropharmacology
Volume: 14,Issue: 4
Page: 322-325
Authors: Wen-Jie Li, Chen Chen, Zhi-Fei You, Ren-Min Yang and Xiao-Ping Wang

Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 10
Page: 983-999
Authors: A. Pirillo, A. L. Catapano and G. D. Norata

Therapeutic Development of Interrelated Metabolic and Neurodegenerative Disorders

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 23
Page: 3608-3618
Authors: Xuan Thi-Anh Nguyen and Ly Le

Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 7
Page: 587-596
Authors: Radzislaw Mierzynski, Dominik Dluski, Dorota Darmochwal-Kolarz, Elzbieta Poniedziałek-Czajkowska, Bozena Leszczynska-Gorzelak, Zaneta Kimber-Trojnar, Agnieszka-Wankowicz and Jan Oleszczuk

Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 14
Page: 1460-1476
Authors: Cristiana Caliceti, Placido Franco, Silvia Spinozzi, Aldo Roda and Arrigo F.G. Cicero

The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer’s Disease

Journal: Current Alzheimer Research
Volume: 13,Issue: 1
Page: 53-67
Authors: M. Florencia Iulita and A. Claudio Cuello

FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?

Journal: Current Diabetes Reviews
Volume: 12,Issue: 3
Page: 223-230
Authors: Anuradha Pandey, Goru Santosh Kumar, Almesh Kadakol, Vajir Malek and Anil Bhanudas Gaikwad

Emerging Potential of Natural Products as an Alternative Strategy to Pharmacological Agents Used Against Metabolic Disorders

Journal: Current Drug Metabolism
Volume: 17,Issue: 6
Page: 582-597
Authors: Tânia R. Dias, Raquel L. Bernardino, Maria J. Meneses, Mário Sousa, Rosália Sá, Marco G. Alves, Branca M. Silva and Pedro F. Oliveira

Autoimmune Disorders during Pregnancy: Effects of Biomarkers on Maternal Serum Screening and Course of Disease

Journal: Current Women`s Health Reviews
Volume: 12,Issue: 2
Page: 95-104
Authors: Gerald J. Mizejewski

Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 15
Page: 2204-2215
Authors: Hajime Sasaki, Kimito Hirai, Christine M. Martins, Hisako Furusho, Ricardo Battaglino and Koshi Hashimoto

Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism

Journal: Current Drug Metabolism
Volume: 17,Issue: 5
Page: 412-429
Authors: Nóra Török, Zsófia Majláth, Ferenc Fülöp, József Toldi and László Vécsei

Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 23
Page: 3317-3324
Authors: Youssef Kouidrat, Ali Amad and Marc De Hert

Previous     Next

Go To   Results 1 - 15 of 5269